January 6, 2015 Patient-Reported Outcomes In Cancer Drug Development And US Regulatory Review: Perspectives From Industry, The Food And Drug Administration, And The Patient
The TREAT-NMD Advisory Committee for Therapeutics (TACT): An Innovative de-Risking Model to Foster Orphan Drug Development
January 4, 2015 Integration of Published Information into a Resistance-Associated Mutation Database for Mycobacterium Tuberculosis
January 4, 2015 Target Product Profile of a Molecular Drug-Susceptibility Test for Use in Microscopy Centers
January 3, 2015 Alzheimer’s and Parkinson’s Diseases Face Common Challenges in Therapeutic Development: Role of the Precompetitive Consortium, Coalition Against Major Diseases
